Physician

Ndelela Nadine Mbuyi, M.D.

According to 2025 Medicare claims, Ndelela Mbuyi, M.D. (NPI: 1467893230) practices rheumatology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is MEDICAL FACULTY ASSOCIATES, INC (NPI: 1417990581; TIN: 522220700) and primary practice location at 20037-3201. Mbuyi is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Mbuyi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 172 traditional Medicare patients, billed 11,566 HCPCS/CPT codes, and received $181,914 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 611 prescription claims across 108 beneficiaries totaling $1,196,698 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 55 records totaling $4,929. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,376 to $181,914. Similarly, Part D prescription costs have risen steadily, from $15,714 to $1,196,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.